AtriCure (ATRC) CEO Files Insider Report on 4,000-Share Charitable Gift

Rhea-AI Filing Summary

AtriCure, Inc. President, CEO, and Director Michael H. Carrel reported a charitable gift of 4,000 shares of AtriCure common stock on 12/10/2025. The transfer is coded as a gift and recorded at a price of $0, reflecting that no consideration was received for the donation. After this transaction, he beneficially owns 687,377 shares directly, with an additional 9,310 shares held by his children and 2,250 shares held by his parents, which he reports as indirect holdings while disclaiming beneficial ownership except for his pecuniary interest.

Insider Trade Summary

Net Seller: 4,000 shares

Net Sell 3 txns

Insider CARREL MICHAEL H

Role President, CEO, & Director

Type	Security	Shares	Price	Value
Gift	Common Stock	4,000	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 687,377 shares (Direct); Common Stock — 9,310 shares (Indirect, Held by reporting person's children); Common Stock — 2,250 shares (Indirect, Held by reporting person's parents)

Footnotes (2)

1. F1. No consideration was received in connection with this charitable gift.
2. F2. The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/12/2025 - 08:26 AM Learn about SEC filing dates

FAQ

What insider stock transaction did AtriCure (ATRC) report in this Form 4?

The report shows that President, CEO, and Director Michael H. Carrel made a charitable gift of 4,000 shares of AtriCure common stock on 12/10/2025, recorded at a price of $0.

Who filed the Form 4 related to AtriCure (ATRC), and what is their role?

The Form 4 was filed by Michael H. Carrel, who serves as AtriCure’s President, CEO, and Director, and is therefore both an officer and director of the company.

How many AtriCure shares does the CEO report owning after the 4,000-share gift?

Following the reported charitable gift, Michael H. Carrel reports 687,377 shares of AtriCure common stock held directly, plus 9,310 shares held by his children and 2,250 shares held by his parents as indirect holdings.

Did the AtriCure CEO receive any payment for the 4,000 shares transferred?

No. The transaction is described as a charitable gift, and the explanation notes that no consideration was received in connection with this transfer of 4,000 shares.

How are shares held by the CEOs family members treated in the AtriCure Form 4?

The Form 4 lists 9,310 shares held by the reporting persons children and 2,250 shares held by his parents as indirect beneficial ownership, and states that he disclaims beneficial ownership of these securities except as to his pecuniary interest.

What does the transaction code "G" mean in the AtriCure (ATRC) Form 4?

The transaction in Table I is labeled with code "G" and is further described in the notes as a charitable gift, indicating a transfer of shares made without receiving payment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CARREL MICHAEL H

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OH 45040-9695

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO, & Director

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		G	V	4,000	D	$0(1)	687,377	D
Common Stock								9,310	I	Held by reporting person's children(2)
Common Stock								2,250	I	Held by reporting person's parents(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. No consideration was received in connection with this charitable gift.

2. The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

Remarks:

	/s/ Michael H. Carrel	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.